END STAGE LIVER DISEASE

This study tests a home-based program called LiverWatch for people with advanced liver disease (cirrhosis). Participants get a Fitbit, personalized nutrition advice, and weekly education. The goal is to see if this helps improve physical activity, diet, and overall well-being com…

This study tests whether a one-time infusion of donor stem cells, combined with low-dose radiation and immune therapy, can retrain the immune system to accept a liver transplant without lifelong anti-rejection drugs. The goal is to safely wean 12 adult liver transplant recipients…

This study is testing whether eating protein evenly throughout the day combined with exercise can improve nutrition, muscle mass, and physical function in 90 adults waiting for a liver transplant. Participants are randomly assigned to one of three groups: even protein distributio…

This early study tests whether siplizumab can safely prevent the immune system from attacking a new liver in people with autoimmune hepatitis or primary sclerosing cholangitis. Eight participants will receive two doses of the drug around the time of transplant and be monitored fo…

This study is testing a web-based app that helps people on the kidney or liver transplant waiting list share their story on social media to find a living donor. The goal is to see if this approach brings in more potential donors and leads to more transplants. The study involves 1…

This study looks at why some people with end-stage liver disease are less likely to be listed for or receive a liver transplant. Researchers will track 100 patients to see who gets on the waiting list and who gets a transplant. The goal is to find ways to make the process fairer …

This study looks at how frailty, nutrition, muscle loss, and mental health affect people waiting for a liver transplant. Researchers will measure physical strength, walking ability, and daily function, along with diet and emotional well-being. The goal is to see which factors pre…